Liquidation risk if no business combination completed within statutory timeframe (typically 24 months from IPO) - results in trust distribution at ~$10.00/share, eliminating sponsor equity value and any premium paid above NAV
Regulatory scrutiny of SPAC structures - SEC has increased disclosure requirements and accounting treatment for warrants, reducing SPAC attractiveness and deal flow since 2021-2022
Structural misalignment where sponsor economics incentivize any deal completion rather than quality deals, potentially leading to value-destructive mergers
Over 600 SPACs launched 2020-2021 competing for limited pool of quality private companies seeking public listings, creating adverse selection problem
Traditional IPO market recovery reduces appeal of SPAC path for high-quality targets, leaving lower-tier companies as available merger candidates
Private equity and strategic acquirers offer competing exit paths for private companies, often at higher valuations without public market disclosure requirements
Current ratio of 0.51 indicates working capital deficit outside trust account - operating expenses may require additional sponsor funding or trust withdrawals
Negative price-to-book of -95.1x suggests market values entity below liquidation value, indicating skepticism about deal completion probability or quality
No debt provides downside protection but limits financial flexibility for larger transactions requiring equity commitment
StructuralCompetitiveBalance Sheet